What is Polidocanol?
Doctor Answers 14
Polidocanol was approved as sclerosing agent in the US in March 2010
and the brand name is Asclera. Polidocanol along with STS are in the "detergent" class of sclerosing agents and considered the safest. The "shadowing" you mention may be post-inflammatory hyperpigmentation (PIH) which sometimes may take up to 1-2 months to resolve. It is also possible that the shadowing is from formation of grouped or matted telangiectasia near the treated vessel. Asclera can cause PIH but less commonly than STS. The rish of this temporary pigmentation can be further minimized by matching the vessel size with the right concentration. Asclera comes in two concentrations: 0.5% and 1.0% The risk of matted telangiectasia can also be minimized by rate of injection and volume of solution used.
Best Technique for Sclerotherapy of Spider Veins
Polidocanol is a sclerosant solution classified as a chemical detergent. It can be used in foam solution sclerotherapy but is not FDA approved in the United States at this time. There are alternative solutions in the United States and these can be administered by a board certified vein specialist.
Polidocanol is an excellent sclerotherapy solution.
Polidocanol(trade name Asclera) is FDA approved and available in the US for the treatment of spider veins. Polidocanol is classified as a detergent meaning that it can be converted into a foam solution for sclerotherapy. It can be used in several different concentrations and is about 1/2 as strong as tetradecyl which is another detergent sclerotherapy solution which has been used for years. In addition to this, polidocanol has minimum side effects and no discomfort on injecting.
You might also like...
A great agent for sclerotherapy
Polidocanol is a sclerosing agent, meaning it is used as an injection,either as a liquid or as a foam, to treat a variety of vein conditions, including telangiectasias, spider veins, reticular veins, and varicose veins. It offers the potential advantage of being more comfortable during injection that other agents (e.g. sodium tetradecyl sulfate, hypertonic saline) as its molecular structure works as an anesthetic (numbing agent) in the area of injection. According to published clinical studies, polidocanol offers a decreased side effect profile compared to other agents used in sclerotherapy, including a decreased chance of pigmentation and ulceration.
Polidocanol and Sotradecol are both considered detergents. They are both FDA approved. The Shadows you mentioned may be either Post Injection Hyperpigmentation which is inflammatory in nature and may take a few months to resolve. It may also be matting. Post injection hyperpigmentation does occur in both but according to most literature to a less degree in asclera.The risk of matting telangiectasias can be minimized by making sure not to rupture the vessel by injecting with too much pressure.
Polidocanol available in US
Polidocanol (Asclera) got U.S. FDA approval March 2010. The "shadowing" you refer to could be temporary discoloration which is still a potential side effect with Asclera. The "shadowing" you refer to may also be matting of veins which is the occurrence of multiple tiny little vessels that show up after having sclerotherapy. That can be treated with Vbeam laser. Asclera still has potential side effects which can be minimized by seeing a skilled provider.
A Sclerosing Solution
Polidocanol ( Aethoxyckerol) is a sclerosing solution very popular in Europe. It has attained its popularity for a variety of reasons. Originally an anesthetic, it is virtually painless upon injection, unlike hypertonic saline which induces quite a bit of pain. Another advantage is that it poses minimal risk of extravasation necrosis as compared with other agents. This allows injectors to be less anxious about causing scarring on our patients.
There are two big drawbacks to using polidocanol in the United States. First, and most importantly, it still has not been approved in the United States. It seems every year, I hear that it will be approved that year. ( I have heard the same thing for 2010). It seems there has been talk of its imminent approval for the last 20 years or so. Thus, if you have a complication, it will be even more difficult for your lawyer to extricate you from a nasty malpractice suit...if you are using a non-FDA approved drug.
The other problem, is that there is an allergic potential. This potential is very small, but happens. I had a patient a few years ago, who told me she went into vascular collapse ( shock), when this was injected by another physician.
Iroinically, most authorities regard Policocanol as no more dangerous than two of its FDA approved competitors, Sodium Morrhuate and Tetradecyl Sulfate.
Polidocanol is a sclerosant used to treat leg veins.
There are several ways to treat spider veins in the legs.
The most common, and still considered the 'gold standard', is with sclerotherapy.
Laser can also be a good option if the vessels are so tiny that it is nearly impossible to cannulate them with a needle and sometimes as an option when treating large, bulging vessels by entering inside of the vessel and sealing them from within.
There are several sclerosants available and all will adequately do the job. Sometimes it is just personal preference from the clinician.
Polydoconol can be obtained and used in the U.S. This is actually the choice method in our office. The average normal concentrations can be 0.25% to a 1.0% solution, depending on vessel size being treated. The shadowing that you are referring to is actually an increase in the pigment of the skin that can occur after the procedure. One significant way to minimize this is to be as sun-free as possible prior to the treatment. Bleaching creams can also help to reduce this effect. By applying the cream prior to the procedure and afterwards can help reduce the chance that the pigment cells will be activated as strongly, and thereby reduces the 'shadowing effect'.
Sclerotherapy and Polidocanol
Polidocanol is a sclerosant used for the treatment of leg veins. While available and popular in Europe, Polidocanol is still not FDA-approved in the United States. It is expected to be approved in the U.S. sometime in 2010. In general, a sclerosing solution (sclerosant) works by causing irritation and inflammation in the wall of the vein into which it is injected. This results in fibrosis of the vessel, followed by occlusion of the lumen, thereby reducing the appearance of the vein (varicosity). It is important for patients to also wear compression garments (prescribed by the physician) following their sclerotherapy treatments. For patients to get excellent results, typically several treatments are required and should be spaced about 4-6 weeks apart.
Polidocanol is coming to US in 2010
Polidocanol is a safe and effective "detergent" or "foaming" solution that has been available in Europe for many years. After more than a decade of studies in the US, FDA approval of polidocanol in the US is expected in 2010. Then physicians will be able to legally use polidocanol for sclerotherapy of unwanted veins.